Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshihide Ishikawa is active.

Publication


Featured researches published by Yoshihide Ishikawa.


Immunogenetics | 1997

Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes

Katsushi Tokunaga; Yoshihide Ishikawa; Atsuko Ogawa; Huiru Wang; Shigeki Mitsunaga; Satoshi Moriyama; Ling Lin; Makoto Bannai; Yoshihisa Watanabe; Kouichi Kashiwase; Hidenori Tanaka; Tatsuya Akaza; Kenji Tadokoro; Takeo Juji

Abstract Alleles of HLA-A, B, C, DRB1, DQB1, and DPB1 loci were fully determined in 117 healthy Japanese. A*2402, A*3303, A*1101, A*0201, B*4403, B*5201, Cw*0102, Cw*1403, Cw*0304, Cw*0702, Cw*0801, and Cw*1202 showed frequencies of over 10%. Multi-locus haplotype frequencies were estimated by the maximum likelihood method. Strength of association between C and B loci was comparable with that between DRB1 and DQB1 loci. Alleles unidentified by a serological method and having very similar nucleotide sequences (A2: A*0201, A*0206, A*0207, B61: B*4002, B*4006) were carried by different haplotypes. Several frequent five-locus haplotypes were identified including A*3303-Cw*1403-B*4403-DRB1*1302-DQB1*0604, and A*2402-Cw*1202-B*5201-DRB1*1502-DQB1*0601. These sequence-based haplotypes corresponded to serology-based common haplotypes which have already been described in Japanese. These findings indicate that common HLA haplotypes consist of particular sets of HLA alleles and that these haplotypes have been conserved through recent human evolution.


Journal of Immunology | 2000

Analysis of Human Vα24+ CD4+ NKT Cells Activated by α-Glycosylceramide-Pulsed Monocyte-Derived Dendritic Cells

Tsuyoshi Takahashi; Mie Nieda; Yasuhiko Koezuka; Andrew Nicol; Steven A. Porcelli; Yoshihide Ishikawa; Kenji Tadokoro; Hisamaru Hirai; Takeo Juji

Human Vα24+ NKT cells with an invariant TCR (Vα24-JαQ) have been shown to be specifically activated by synthetic glycolipids such as α-galactosylceramide and α-glucosylceramide in a CD1d-restricted and Vα24 TCR-mediated manner. We recently characterized Vα24+ CD4− CD8− double negative (DN) NKT cells using α-galactosylceramide-pulsed monocyte-derived dendritic cells. Here, we compare Vα24+ CD4+ NKT cells with human Vα24+ DN NKT cells from the same donor using α-galactosylceramide-pulsed monocyte-derived dendritic cells. Human Vα24+ CD4+ NKT cells were phenotypically and functionally similar to the human Vα24+ DN NKT cells characterized previously. Both of them use Vα24-JαQ-Vβ11 TCR and express CD161 (NKR-P1A), but not the other NK receptors tested so far. They also produce cytokines such as IL-4 and IFN-γ, and, in regard to IL-4 production, Vα24+ CD4+ NKT cells produce more IL-4 than Vα24+ DN NKT cells. The cells exhibit marked cytotoxic activity against the U937 tumor cell line, but not against the NK target cell line, K562. Although at least some of the factors responsible for the stimulation of Vα24+ NKT cells have been clarified, little is known regarding the killing phase of these cells. Here we show that the cytotoxic activity of Vα24+ NKT cells against U937 cells is mediated mainly through the perforin pathway and that ICAM-1/LFA-1 as well as CD44/hyaluronic acid interactions are important for the effector phase of Vα24+ NKT cell-mediated cytotoxicity against U937 cells.


Human Genetics | 1996

Extensive polymorphism of ABO blood group gene: three major lineages of the alleles for the common ABO phenotypes

Kenichi Ogasawara; Makoto Bannai; Naruya Saitou; Ryuichi Yabe; Kenichi Nakata; Michiko Takenaka; Kiyoshi Fujisawa; Makoto Uchikawa; Yoshihide Ishikawa; Takeo Juji; Katsushi Tokunaga

Polymorphism of the ABO blood group gene was investigated in 262 healthy Japanese donors by a polymerase chain reactions-single-strand conformation polymorphism (PCR-SSCP) method, and 13 different alleles were identified. The number of alleles identified in each group was 4 for A1 (provisionally called ABO*A101, *A102, *A103 and *A104 according to the guidelines for human gene nomenclature), 3 for B (ABO*B101, *B102 and *B103), and 6 for O (ABO*O101, *O102, *O103, *O201, *O202 and *O203). Nucleotide sequences of the amplified fragments with different SSCP patterns were determined by direct sequencing. Phylogenetic network analysis revealed that these alleles could be classified into three major lineages, *A/*O1, *B and *O2. In Japanese, *A102 and *13101 were the predominant alleles with frequencies of 83% and 97% in each group, respectively, whereas in group O, two common alleles, *O101 (43%) and *O201 (53%), were observed. These results may be useful for the establishment of ABO genotyping, and these newly described ABO alleles would be advantageous indicators for population studies.


Human Immunology | 1999

Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner

Mie Nieda; Andrew J. Nicol; Yasuhiko Koezuka; Akiko Kikuchi; Tsuyoshi Takahashi; Hiromi Nakamura; Hiroshi Furukawa; Toshio Yabe; Yoshihide Ishikawa; Kenji Tadokoro; Takeo Juji

Vα14NK(natural killer) T cells play an important role in controlling tumors or in preventing autoimmunity in the murine system. Vα24NKT cells, the human counterpart of Vα14NKT cells, may contribute to controlling the progression of autoimmune diseases in humans. These findings show the possibility that ligand(s) for these NKT cells can control the above-mentioned pathological conditions. Specific glycolipids such as α-galactosylceramide (α-GalCer) and α-glucosylceramide (α-GlcCer) have been identified as ligand(s) recognized by murine Vα14NKT cells in a CD1d-restricted manner, but it remains unclear whether these glycolipids are ligand(s) for Vα24NKT cells in humans. To determine whether α-glycosylceramide is presented by CD1d molecules in humans, we initially established a Vα24NKT cell line specific for α-glycosylceramide using dendritic cell (DC) like cells from normal peripheral blood mononuclear cells (PBMC) in an autologous mixed leukocyte reaction (auto-MLR) system, and characterized the Vα24NKT cell line. The Vα24NKT cells were CD3+CD4−CD8−Vα24+Vβ11+NKRP1A+ and specifically proliferated in response to α-glycosylceramide in CD1d-restricted and Vα24TCR-mediated manner. The phenotypic and functional similarities between murine Vα14NKT cells and human Vα24NKT cells suggest that Vα24NKT cells may play an important role in controlling tumors or in preventing autoimmunity as observed with Vα14NKT cells.


Transfusion | 2005

Secondary anti‐D immunization by Del red blood cells

Hitoshi Ohto; Shizue Sakuma; Yoshihide Ishikawa

BACKGROUND:  Recent molecular studies of the RHD gene have revealed that Del individuals retain a grossly intact RHD gene or have a portion of RHD in their genomes. No Del phenotype has yet been shown to induce a primary or secondary alloanti‐D immunization, however.


European Journal of Immunology | 1999

CD8 + NKR-P1A + T cells preferentially accumulate in human liver

Soichiro Ishihara; Mie Nieda; Joji Kitayama; Takuya Osada; Toshio Yabe; Yoshihide Ishikawa; Hirokazu Nagawa; Tetsuichiro Muto; Takeo Juji

A unique subset of T cells that co‐express NKR‐P1, which is a lectin type of NK receptor and is thought to have a major role in triggering NK activity, has been identified. In mice, NK1.1 (mouse NKR‐P1C)+ T cells, called NKT cells, preferentially accumulate in the liver and bone marrow. They predominantly use invariant Vα14 chain TCR and phenotypically are CD4+CD8− or CD4−CD8− T cells. In this study, we analyzed, phenotypically and functionally, the NKR‐P1A (analogue of murine NKR‐P1C)+ T cells resident in the human liver. Here, we show that in complete contrast to the NKT cells in the mouse liver, the majority of NKR‐P1A+ T cells in the human liver are CD8+ and their TCR repertoire is not skewed to Vα24 TCR, the homologue of murine Vα14 TCR. Almost all of the NKR‐P1A+ T cells in the human liver expressed CD69, suggesting that they were activated. Furthermore, the NKR‐P1A+ T cells in the human liver exhibited strong cytotoxicity against a variety of tumor cell lines including K562, Molt4 and some colonic adenocarcinoma cell lines.


Immunogenetics | 1999

MIC-A polymorphism in Japanese and a MIC-A-MIC-B null haplotype.

Miki Komatsu-Wakui; Katsushi Tokunaga; Yoshihide Ishikawa; Kouichi Kashiwase; Satoshi Moriyama; Naoyuki Tsuchiya; Hitoshi Ando; Takashi Shiina; Daniel E. Geraghty; Hidetoshi Inoko; Takeo Juji

Abstract A polymorphic gene, MIC-A, is one of the MIC family of genes which is composed of a group of homologous genes interspersed in the class III and class I regions of the major histocompatibility complex. MIC-A is located 46 kilobases (kb) centromeric of HLA-B, and is preferentially expressed in the epithelial cells and intestinal mucosa. Recently, MIC-A and the closely related MIC-B were reported as the molecules that conferred specificity in the recognition by the Vδ1γδT cells. In the present study, polymorphic exons 2, 3, and 4 of the MIC-A gene were analyzed using the polymerase chain reaction-single-strand conformation polymorphism method. The number of patterns found in exons 2, 3, and 4 were 5, 6, and 4, respectively, in 114 healthy Japanese subjects. Eight MIC-A alleles were observed in Japanese individuals, among which one, tentatively named MIC-AMW, has not previously been reported. There was a strong linkage disequilibrium between MIC-A and HLA-B loci: each MIC-A allele showed strong association with a particular HLA-B group. In contrast, B*3901 showed association with multiple MIC-A alleles. Furthermore, the existence of a MIC-A-MIC-B null haplotype, which is associated with HLA-B*4801, was identified. In this haplotype, a large-scale deletion (of approximately 100 kb) including the entire MIC-A gene was indicated and the MIC-B gene possessed a stop codon.


Journal of Clinical Investigation | 1999

Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome

Hiroshi Furukawa; Shigeo Murata; Toshio Yabe; Naoki Shimbara; Naoto Keicho; Kouichi Kashiwase; Kaoru Watanabe; Yoshihide Ishikawa; Tatsuya Akaza; Kenji Tadokoro; Shigeto Tohma; Tetsufumi Inoue; Katsushi Tokunaga; Kazuhiko Yamamoto; Keiji Tanaka; Takeo Juji

Expression of histocompatibility leukocyte antigen (HLA) class I molecules on the cell surface depends on the heterodimer of the transporter associated with antigen processing 1 and 2 (TAP1 and TAP2), which transport peptides cleaved by proteasome to the class I molecules. Defects in the TAP2 protein have been reported in two families with HLA class I deficiency, the so-called bare lymphocyte syndrome (BLS) type I. We have, to our knowledge, identified for the first time a splice site mutation in the TAP1 gene of another BLS patient. In addition, class I heavy chains (HCs) did not form the normal complex with tapasin in the endoplasmic reticulum (ER) of the cells of our patient.


Immunogenetics | 1995

HLA-A null allele with a stop codon, HLA-A*0215N, identified in a homozygous state in a healthy adult.

Yoshihide Ishikawa; Katsushi Tokunaga; Hidenori Tanaka; Motoko Nishimura; Masato Muraoka; Yasuhiko Fujii; Tatsuya Akaza; Kenji Tadokoro; Takeo Juji

A healthy adult having no serologically detectable HLA class I A locus antigens was identified. The parents of the individual are consanguineous. Results of a family study indicated that the individual is homozygous for the B46-Cw1-DR8.1 haplotype, which was shown to be positively associated with A*0207 in our previous study. The HLA-A null individual is healthy and exhibits no apparent immunological abnormality. Total RNAs extracted from peripheral blood were converted to cDNAs. The reverse transcriptase-polymerase chain reaction (PCR) product, which is of the same size as the normally expressed gene, was easily obtained from the cDNAs with HLA-A locus-specific primers. The nucleotide sequence of this null allele (A*0215N) was the same as that of A*0207 except for a single nucleotide substitution which resulted in a stop codon in exon 4. From its nucleotide sequence, a truncated molecule was expected to be produced; however, the immunoprecipitation study failed to detect the predicted product. Genomic DNAs from 29 unrelated individuals who expressed only one HLA-A antigen with HLA-B46, were analyzed by a PCR-sequence-specific oligonucleotide method. None of the samples possessed this stop codon. Therefore, A*0215N is likely to be a rare allele generated by a single point mutation from A*0207.


Vox Sanguinis | 1983

Prevention of Leakage of Di-(2-ethylhexyl)phthalate from Blood Bags by Glow Discharge Treatment and Its Effect on Aggregability of Stored Platelets

Yoshihide Ishikawa; Kenji Honda; Shigeru Sasakawa; Kenji Halada; Hiroaki Kobayashi

Abstract. Platelets storage in glow discharge treated PVC bags was studied. The amount of leaked di‐(2‐ethylhexyl) phthalate (DEHP) was 150–200 μg/ml/day in the nontreated PVC bags, but only 20–40 μg/ml in the treated bags after 48 h. The adhesion of silicone to PVC was much improved, and consequently, uniform coating with silicone became feasible. The decrease of the ability of platelets to aggregate was accelerated by DEHP. When stored platelets were resuspended in fresh plasma, the ability to aggregate was gradually restored. However, the degree of restoration of the ability of platelets which had been incubated with DEHP was low. When platelets were stored in the glow discharge treated and then silicone‐coated PVC bags, their adhesion on the surface and the decrease of their function were prevented.

Collaboration


Dive into the Yoshihide Ishikawa's collaboration.

Top Co-Authors

Avatar

Takeo Juji

Gulf Coast Regional Blood Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenji Tadokoro

Gulf Coast Regional Blood Center

View shared research outputs
Top Co-Authors

Avatar

Tatsuya Akaza

Gulf Coast Regional Blood Center

View shared research outputs
Top Co-Authors

Avatar

Kouichi Kashiwase

Gulf Coast Regional Blood Center

View shared research outputs
Top Co-Authors

Avatar

Shigeru Sasakawa

Gulf Coast Regional Blood Center

View shared research outputs
Top Co-Authors

Avatar

Atsuko Ogawa

Gulf Coast Regional Blood Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hidenori Tanaka

Gulf Coast Regional Blood Center

View shared research outputs
Top Co-Authors

Avatar

Makoto Uchikawa

Gulf Coast Regional Blood Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge